| Report ID | 276401 |
| Drug Identification Number | 02231590 |
| Brand name | ABELCET |
| Common or Proper name | Amphotericin B Lipid Complex Injection |
| Company Name | LEADIANT BIOSCIENCES, INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | AMPHOTERICIN B |
| Strength(s) | 5MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 20mL vial |
| ATC code | J02AA |
| ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2025-07-25 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2000 ELLESMERE ROAD SCARBOROUGH, ONTARIO CANADA M1H 2W4 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-01-21 | French | Compare |
| v1 | 2026-01-21 | English | Compare |
Showing 1 to 2 of 2